Long non-coding RNASNHG17 promotes the progression of breast cancer by sponging miR-124-3p

被引:43
作者
Du, Ye [1 ]
Wei, Na [2 ]
Hong, Jinghui [1 ]
Pan, Weiyun [3 ]
机构
[1] Jilin Univ, Dept Breast Surg, Hosp 1, Changchun 130021, Jilin, Peoples R China
[2] Jilin Univ, Dept Operating Room 1, Hosp 1, Changchun 130021, Jilin, Peoples R China
[3] Jilin Univ, Dept ICU, Hosp 1, Changchun 130021, Jilin, Peoples R China
关键词
Breast cancer; SNHG17; miR-124-3p; CELL-PROLIFERATION; RNA SNHG17; METASTASIS; TARGETS;
D O I
10.1186/s12935-020-1129-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Small nucleolar RNA host gene 17 (SNHG17), a novel cancer-related long noncoding RNA (lncRNA), was reported to be responsible for processing and developing in several cancers. Nonetheless, the clinical significance and biological function of SNHG17 in human breast cancer (BC) remain rarely known. Materials and methods 58 pairs of BC tissues and adjacent non-cancerous tissues were harvested to measure SNHG17 expression levels. SNHG17 was knockdown to study its biological behavior in BC cells. The microRNAs (miRNAs) that can bind to SNHG17 were predicated using Starbase2.0 and were tested using luciferase reporter activity and RIP assays. A xenograft model was established to investigate the impact of SNHG17 in tumor growth in vivo. Results An increased SNHG17 was observed in BC samples and cell lines compared with corresponding control. Increased SNHG17 was closely associated with poor prognosis.SNHG17 depletion suppressed cell proliferation, migration and invasion in vitro, as well as inhibited tumor growth in xenograft tumor models. Mechanistically, SNHG17 could function as an endogenous sponge of miR-124-3p in BC cells. Moreover, the repression of cell proliferation, migration and invasion induced by SNHG17 knockdown would reversed by miR-124-3p inhibitor. Conclusion The present study demonstrated that the lncRNASNHG17 could regulate the progression of BC by sponging miR-124-3p.
引用
收藏
页数:9
相关论文
共 27 条
[1]   Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer [J].
Abdollahzadeh, Rasoul ;
Daraei, Abdolreza ;
Mansoori, Yaser ;
Sepahvand, Masoumeh ;
Amoli, Mahsa M. ;
Tavakkoly-Bazzaz, Javad .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) :10080-10100
[2]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[3]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[4]  
Chen LL, 2019, EUR REV MED PHARMACO, V23, P1063, DOI 10.26355/eurrev_201902_16994
[5]  
Dong YP, 2019, AM J CANCER RES, V9, P1469
[6]   Living with Metastatic Breast Cancer [J].
Ganz, Patricia A. ;
Stanton, Annette L. .
IMPROVING OUTCOMES FOR BREAST CANCER SURVIVORS: PERSPECTIVES ON RESEARCH CHALLENGES AND OPPORTUNITIES, 2015, 862 :243-254
[7]   STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway [J].
Gao, H. ;
Liu, R. ;
Sun, X. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (18) :8000-8010
[8]   The emerging role of IncRNAs in cancer [J].
Huarte, Maite .
NATURE MEDICINE, 2015, 21 (11) :1253-1261
[9]   Sperm Associated Antigen 9 Plays an Important Role in Bladder Transitional Cell Carcinoma [J].
Kanojia, Deepika ;
Garg, Manoj ;
Saini, Shikha ;
Agarwal, Sumit ;
Parashar, Deepak ;
Jagadish, Nirmala ;
Seth, Amlesh ;
Bhatnagar, Amar ;
Gupta, Anju ;
Kumar, Rajive ;
Lohiya, Nirmal Kumar ;
Suri, Anil .
PLOS ONE, 2013, 8 (12)
[10]   Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer [J].
Luisa Pecero, Ma ;
Salvador-Bofill, Javier ;
Molina-Pinelo, Sonia .
CELLULAR ONCOLOGY, 2019, 42 (01) :1-12